OPKO Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OPKO Health, Inc. on January 6, 2020. The report discloses a corporate governance event regarding the appointment of a new member to the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The material change reported is the appointment of Anthony Japour, M.D., as a new director, effective January 6, 2020. Dr. Japour was appointed to serve until the Company's 2020 Annual Meeting of Stockholders or until his successor is elected. The Board determined that Dr. Japour is independent under SEC and Nasdaq rules. He will serve on the Compensation and Audit Committees.
Outlook, Risks, and Management Commentary
There is no forward-looking guidance, risk disclosure, or management commentary regarding business operations in this filing. The report notes that Dr. Japour will participate in standard non-employee director compensation arrangements and has entered into a standard director indemnification agreement. No related person transactions or special arrangements were identified.
Key Facts for Investor Verification
- Anthony Japour, M.D., was appointed to the Board of Directors effective January 6, 2020.
- Dr. Japour is designated as an independent director.
- He will serve on the Compensation and Audit Committees.
- His compensation follows the standard arrangements detailed in the 2019 Proxy Statement.
- The filing contains no financial results or operational updates.